Abstract
Tobacco use is the single most important cause of preventable illness and premature death. Currently, tobacco use causes an estimated 3 million annual deaths worldwide (1,2). The financial burden of smoking-related diseases is also substantial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Peto R. Smoking and death: the past 40 years and the next 40. Br Med J 1994; 309:937–939.
Fagerstrom K. The epidemiology of smoking. Health consequences and benefits of cessation. Drugs 2002;62(Suppl 2):1–9.
Mitchell BE, Sobel HL, Alexander MH. The adverse health effects of tobacco and tobacco-related products. Primary Care 1999;26:463–499.
Shinton R, Beeves G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J 1989;298:789–794.
Hawkins BT, Brown RC, Davis TP. Smoking and ischemic stroke: a role for nicotine? TIPS 2002;23(2):78–82.
You RX, Thrift AG, McNeirl JJ, Davis SM, Donnan GA. Ischemic stroke risk and passive exposure to spouses’ cigarette smoking. Am J Pub Health 1999;89:572–575.
Law MR, Hackshaw AK. Environmental tobacco smoke. Br Med Bull 1996;52: 22–33.
Howard G, Wegenknecht LE, Cai J, et al. Cigarette smoking and progression of atherosclerosis; the Atherosclerosis Risk In Communities (ARIC) Study. JAMA 1998; 279:119–124.
The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109–2118.
Weir BK, Kongable GL, Kassell NF, et al. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm. A report of the Cooperative Aneurysm Study. J Neurosurg 1998;89:405–411.
Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: metaanalysis of cohort studies. Arch Intern Med 2000; 160:939–944.
Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and the decreased risk of stroke in women. JAMA 1993;269:232–236.
Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274:155–160.
Shinton R. Lifelong exposures and the potential for stroke prevention: the contribution of cigarette smoking, exercise, and body fat. J Epidemiol Community Health 1997;51;138–143.
The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical guideline for treating tobacco use and dependence. A US Public Health Service Report. JAMA 2000;283:3244–3254.
Silagy C, Stead LF. Physician advice for smoking cessation. Cochrane Database Syst Rev 2002;(2):CD000165.
Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary and other atherosclerotic vascular diseases. Circulation 2002;106:388–391.
West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals. Thorax 2000;55:987–999.
Corelli RL. Medications for smoking cessation. West J Med 2002;176:131–135.
Sutherland G. Current approaches to the management of smoking cessation. Drugs 2002;62(suppl 2):53–61.
Henningfield JE, Fant RV, Gitchell J, et al. Tobacco dependence: global public health potential for new medications development and indications. Ann NY Acad Sci 2000;909:247–256.
Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002;(4):CD000146.
Jorenby D. Clinical efficacy of bupropion in the management of smoking cessation. Drugs 2002;62(Suppl 2):25–35.
Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2002;(1):CD000031.
Aubin HJ. Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs 2002;62(Suppl 2):45–52.
Coleman T. Smoking cessation: Integrating recent advances into clinical practice. Thorax 2001;56:579–582.
Gatte KM, Parker CB, Maner LG, et al. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obesity Res 2001;9: 544–541.
Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation. Cochrane Database Syst Rev 2000;(2):CD00058.
Lancaster T, Stead LF. Mecamylamine (a nicotine antagonist) for smoking cessation. Cochrane Database Syst Rev 2000;(2):CD001009.
West R. Glucose for smoking cessation: does it have a role? CNS Drugs 2001;15: 261–265.
Schoenberger JS. Preventive cardiology: cardiovascular risk of smoking and benefits of smoking cessation. UpToDate Online. Version 10.2,2002. Available at: http://uptodateonline.com. Accessed July 7,2002.
Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull 1996;52:58–73.
Godfrey C, Fowler G. Pharmacoeconomic considerations in the management of smoking cessation. Drugs 2002;62(Suppl 2):63–70.
Hillboom M, Numminen H, Juvela S. Recent heavy drinking of alcohol and embolic stroke. Stroke 1999;30:2307–2312.
Hillbom M, Juvela S, Numminen H. Alcohol intake and the risk of stroke. J Cardiovasc Risk 1999;6:223–228.
Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003;289:579–588.
Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999;281:53–60.
Malarcher AM, Giles WH, Croft JB, et al. Alcohol intake, type of beverage, and the risk of cerebral infarction in young women. Stroke 2001;32:77–83.
Caicoya M, Rodriguez T, Corrales C, Cuello R, Lasheras C. Alcohol and stroke: a community case-control study in Asturias, Spain. J Clin Epidemiol 1999;52:677–684.
Camargo CA Jr. Moderate alcohol consumption and stroke. The epidemiologic evidence. Stroke 1989;20:1611–1626.
Jackson VA, Sesso HD, Buring JE, Gaziano JM. Alcohol consumption and mortality in men with preexisting cerebrovascular disease. Arch Intern Med 2003;163: 1189–1193.
Djousse L, Pankow JS, Arnett DK, et al. Alcohol consumption and risk of ischemic stroke: the Framingham Study. Stroke 2002;33:907–912.
Truelsen T, Gronbaek M, Schnohr P, Boysen G. Intake of beer, wine, and spirits and risk of stroke: the Copenhagen City Heart Study. Stroke 1998;29:2467–2472.
Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 1996;27:1033–1039.
Hansagi H, Romelsjo A, Gerhardsson de Verdier M, Andreasson S, Leifman A. Alcohol consumption and stroke mortality. 20-year follow-up of 15,077 men and women. Stroke 1995;26:1768–1773.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Topcuoglu, M.A., Furie, K.L. (2004). Tobacco and Alcohol. In: Furie, K.L., Kelly, P.J. (eds) Handbook of Stroke Prevention in Clinical Practice. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-769-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-769-7_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9856-1
Online ISBN: 978-1-59259-769-7
eBook Packages: Springer Book Archive